EpiVax's Grant - XIX Round

EpiVax raised a round of funding on November 11, 2010.

EpiVax, is a privately held biotechnology company focused on the development of vaccines and immunotherapies for infectious diseases, autoimmunity and cancer. The immunoinformatics team at EpiVax has …

Articles about EpiVax's Grant - XIX Round: